SCHEMBL8031160

SCHEMBL8031160

CCOC(=O)N1C(=O)C(=Cc2ccccc2)c2ccc(Cl)cc21

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 4/20 0.60
▸ APP P05067 2/20 0.60
▸ SNCA P37840 2/20 0.60
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ ALDH1A1 P00352 2/20 0.44
▸ MDM2 Q00987 2/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ NPSR1 Q6W5P4 1/20 0.44
▸ PPARG P37231 3/20 0.42
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ LRRK2 Q5S007 1/20 0.40
▸ HTT P42858 2/20 0.40
▸ TGM2 P21980 1/20 0.40
▸ TSHR P16473 1/20 0.40
▸ MDM4 O15151 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ RXRA P19793 1/20 0.39
▸ ADORA3 P0DMS8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4709524 0.94 MAPT (0.60) MAPTAPPSNCAMEN1KMT2A
SCHEMBL1022200 0.94 MAPT (0.60) MAPTAPPSNCAMEN1KMT2A
SCHEMBL1022199 0.94 MAPT (0.60) MAPTAPPSNCAMEN1KMT2A
SCHEMBL4719164 0.93 MAPT (0.54) MAPTAPPSNCAMEN1KMT2A
SCHEMBL8226301 0.93 MAPT (0.54) MAPTAPPSNCAMEN1KMT2A
SCHEMBL699531 0.85 MAPT (0.43) MAPTAPPSNCAMEN1KMT2A
SCHEMBL14419503 0.81 MAPT (0.44) MAPTAPPSNCAMEN1KMT2A
SCHEMBL3361592 0.81 MAPT (0.44) MAPTAPPSNCAMEN1KMT2A
SCHEMBL3361587 0.81 MAPT (0.44) MAPTAPPSNCAMEN1KMT2A
SCHEMBL277025 0.79 MDM4 (0.43) MAPTAPPSNCAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7495007-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2009-02-24 — — US disclosed
US-7495007-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2009-02-24 — — US disclosed
US-20080188506-A1 SPIROINDOLINONE DERIVATIVES DING QINGJIE 2008-08-07 — — US disclosed
US-20080188506-A1 SPIROINDOLINONE DERIVATIVES DING QINGJIE 2008-08-07 — — US disclosed
US-20080009486-A1 SPIROINDOLINONE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-01-10 — — US disclosed
US-20080009486-A1 SPIROINDOLINONE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-01-10 — — US disclosed
WO-2007104714-A1 SPIROINDOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-09-20 — — WO disclosed
WO-2007104664-A1 SPIROINDOLINONE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2007-09-20 — — WO disclosed
US-20070213341-A1 Spiroindolinone derivatives CHEN LI 2007-09-13 — — US disclosed
US-20070213341-A1 Spiroindolinone derivatives CHEN LI 2007-09-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009486-A1 SPIROINDOLINONE DERIVATIVES RB1, PKD1, KRAS MAPT 4581/4885APP 4782/4885SNCA 2624/4885
US-20080188506-A1 SPIROINDOLINONE DERIVATIVES MKI67, MCL1, BAD MAPT 4092/4885APP 4809/4885SNCA 2300/4885
US-20070213341-A1 Spiroindolinone derivatives MKI67, PKD1, RCC2 MAPT 4139/4885APP 4835/4885SNCA 2732/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback